secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0000950170-23-032518
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health prices $1.8M public offering of 32.5M shares at $0.055/share
-------------------------------------------------------------------------

- Sold 32.5M shares at $0.055/share; gross proceeds ~$1.8M, net ~$1.6M after fees and expenses.
- Maxim Group received 8% cash fee ($143K) and warrants for 1.3M shares at $0.066 exercise price.
- Net proceeds will be used for working capital and general corporate purposes.
- Offering closed July 11, 2023; officers and directors subject to 30-day lock-up agreements.
- Offered under effective shelf registration on Form S-3 (file 333-269494).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023032518/0000950170-23-032518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023032518/tivc-20230710.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-032518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer